Suppr超能文献

增殖性玻璃体视网膜病变——辅助治疗及视网膜病理学的进展

Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology.

作者信息

Charteris D G, Sethi C S, Lewis G P, Fisher S K

机构信息

Moorfields Eye Hospital NHS Trust City Road London EC1V 2PD UK.

出版信息

Eye (Lond). 2002 Jul;16(4):369-74. doi: 10.1038/sj.eye.6700194.

Abstract

Proliferative vitreoretinopathy (PVR) remains a difficult management problem despite advances in vitreoretinal surgery. There is still a significant incidence of PVR in rhegmatogenous retinal detachment and other forms of retinal disease. Surgery for PVR now has a high anatomical success rate although visual results are often disappointing. The use of adjunctive treatments to prevent cellular proliferation holds promise for the prevention of PVR or recurrences after surgery. Control of proliferation and strategies aimed at improving visual outcome are important areas of future research in PVR and other forms of retinal disease. Studies of the intraretinal and peri-retinal pathology of PVR have demonstrated characteristic changes which may have a significant influence on visual outcome and surgical management.

摘要

尽管玻璃体视网膜手术取得了进展,但增殖性玻璃体视网膜病变(PVR)仍然是一个难以处理的问题。在孔源性视网膜脱离和其他形式的视网膜疾病中,PVR的发病率仍然很高。尽管视觉效果往往令人失望,但目前PVR手术的解剖学成功率很高。使用辅助治疗来防止细胞增殖有望预防PVR或手术后复发。控制增殖以及旨在改善视觉结果的策略是PVR和其他形式视网膜疾病未来研究的重要领域。对PVR视网膜内和视网膜周围病理学的研究已经证明了一些特征性变化,这些变化可能对视觉结果和手术治疗产生重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验